Clinical Trials on SARS (Severe Acute Respiratory Syndrome) in United Kingdom

Total 4401 results

University of Minnesota
National Institute of Allergy and Infectious Diseases (NIAID); National Institutes... and other collaborators

Completed

Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)

COVID-19 | COVID | SARS-CoV-2 | SARS (Severe Acute Respiratory Syndrome)

Spain, United States, Denmark, United Kingdom, Greece, Japan, Nigeria
NeuroActiva, Inc.
Biomed Industries, Inc.

Unknown

A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19 (OPV-NA831)

Covid19 | SARS-CoV-2 | SARS-CoV Infection | SARS (Severe Acute Respiratory Syndrome)

New Zealand, United States
University of Washington
Bill and Melinda Gates Foundation

Completed

Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP)

COVID-19 | Corona Virus Infection | SARS-CoV-2 | SARS (Severe Acute Respiratory Syndrome)

United States
Portsmouth Hospitals NHS Trust

Completed

A Feasibility Study Using the CoronaCheck Device to Identify Incident Cases of SARS CoV-2 Covid-19

SARS-CoV Infection

United Kingdom
University of Washington
National Institute of Allergy and Infectious Diseases (NIAID); Fred Hutchinson...

Completed

Index Individuals in SARS-CoV-2 Prevention Research Studies (COVID-19 Index Individuals Companion Study) (IICov19PRS)

COVID-19 | Coronavirus Infection | SARS-CoV-2 Infection | SARS (Severe Acute Respiratory Syndrome)

United States
Cambridge University Hospitals NHS Foundation Trust

Unknown

Dysphagia and Dysphonia Outcomes in SARS CoV-2 (COVID-19) Infection (DYADS Study) (DYADS)

Quality of Life | Covid19 | Dysphagia | SARS-CoV-2 Infection | SARS (Severe Acute Respiratory Syndrome) | Dysphonia | Voice Disorders | Swallowing Disorder | SARS Pneumonia | Subglottic Stenosis

United Kingdom
Massachusetts General Hospital
Xijing Hospital; Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico; Niguarda...

Completed

Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19 (NOSARSCOVID)

Coronavirus | SARS (Severe Acute Respiratory Syndrome)

United States, Sweden
Cogna Technology Solutions LLC
Novavax

Completed

Phase 3 Boosting Study for the SARS-CoV-2 rS Vaccine

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

United Arab Emirates
Rigel Pharmaceuticals

Completed

Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects

Pneumonia, Viral | Pneumonia | Covid19 | SARS (Severe Acute Respiratory Syndrome) | SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere | SARS Pneumonia

United States, Argentina, Brazil, Mexico
Imperial College London

Completed

Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19) (PREDICT-ILI)

RNA Virus Infections | Respiratory Tract Infections | Covid19 | Influenza | Infection, Bacterial | SARS (Severe Acute Respiratory Syndrome) | Respiratory Viral Infection | Infection Viral

United Kingdom
Saint Francis Care

Completed

Convalescent Plasma in the Treatment of COVID 19

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | COVID | Coronavirus

United States
NeuroActiva, Inc.

Unknown

Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831 (NEUROSIVIR)

Severe Acute Respiratory Syndrome | Covid19 | Corona Virus Infection | Severe Acute Respiratory Syndrome (SARS) Pneumonia | Neurodegeneration | Neuroinflammatory Response | Severe Acute Respiratory Infection | Severe Acute Respiratory Syndrome of Upper Respiratory Tract

United States
University College, London
Francis Crick Institute

Recruiting

SARS-CoV-2 (COVID-19) Longitudinal Study: Understanding Susceptibility, Transmission and Disease Severity (Legacy Study)

SARS-CoV Infection

United Kingdom
Pine Trees, Inc.
Piedmont Healthcare; ICON plc; MRI Global; ASCLEPES Research Center; Eastside Research... and other collaborators

Completed

A Clinical Evaluation of Pine Trees Health Test System Including the Pine Trees Health Reader and COVID-19 Test for Point-of-Care

Covid19 | SARS (Severe Acute Respiratory Syndrome)

United States
AbbVie

Completed

A Study to Assess Infection Rate of Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2) and It's Affect on Quality of Life in Adult Volunteers in Lake County, Illinois (CONTACT)

Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2)

United States
William Beaumont Hospitals

Terminated

ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS) (ABACCuS)

Coronavirus Infections | COVID-19 | Severe Acute Respiratory Syndrome (SARS)

United States
Lucira Health Inc

Completed

A Study To Evaluate The Performance of the Lucira Health All-In-One COVID-19 Test Kit vs Hologic Panther Fusion

Covid19 | Corona Virus Infection | SARS (Severe Acute Respiratory Syndrome)

United States
Quadram Institute Bioscience
Norfolk and Norwich University Hospitals NHS Foundation Trust; James Paget...

Active, not recruiting

COVID-19 Persistence in Stool (CoPS)

SARS-CoV Infection

United Kingdom
King's College London
Guy's & St Thomas NHS Foundation Trust

Withdrawn

LIBERATE Trial in COVID-19 (LIBERATE)

Respiratory Distress Syndrome | SARS-CoV Infection | Coronavirus

United Kingdom
Emory University
National Cancer Institute (NCI)

Terminated

Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19 (RESCUE 1-19)

Pneumonia | Coronavirus Infection in 2019 (COVID-19) | Severe Acute Respiratory Syndrome (SARS) Pneumonia

United States
University of Minnesota
National Institute of Allergy and Infectious Diseases (NIAID); National Institutes...

Recruiting

Respiratory Virus Hospitalization Study (FLU 003 Plus)

Influenza | Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV) | Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)

United States, Australia, Spain, Denmark, Greece, Argentina, United Kingdom, Belgium, Chile, Germany, Peru, Thailand
National Institute of Allergy and Infectious Diseases...
PPD; University of Washington; Vanderbilt University Medical Center; Implicit Bioscience

Terminated

COVID-19 and Anti-CD14 Treatment Trial (CaTT)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Coronavirus Disease 2019 (COVID-19)

United States
Imperial College London
Royal Free Hospital NHS Foundation Trust; Hvivo

Completed

SARS-CoV-2 Human Challenge Characterisation Study

COVID-19 | Covid19 | Corona Virus Infection | SARS-CoV Infection | Coronavirus

United Kingdom
William Beaumont Hospitals

Terminated

Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19 (SINK COVID-19)

Coronavirus Infections | COVID-19 | Acute Respiratory Distress Syndrome | Severe Acute Respiratory Syndrome (SARS)

United States
BioNTech SE
Pfizer

Recruiting

A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children

COVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2 | SARS-CoV-2 Virus

United States, Brazil, Puerto Rico
Chelsea and Westminster NHS Foundation Trust

Completed

Lung Ultrasound Changes in Covid 19 Patients Discharged From Hospital

Coronavirus Infection | Covid19 | SARS-CoV Infection | Coronavirus

United Kingdom
Chelsea and Westminster NHS Foundation Trust

Completed

Lung Ultrasound Findings in Patients With COVID-19 in a UK ED

Covid19 | Corona Virus Infection | SARS-CoV Infection | Coronavirus

United Kingdom
Inovio Pharmaceuticals
Advaccine (Suzhou) Biopharmaceuticals Co., Ltd.

Terminated

Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Coronavirus Infection | COVID-19 Disease

United States, Mexico, Colombia
University of Texas Southwestern Medical Center

Terminated

Cardiovascular Implications of COVID-19

COVID-19 | SARS-CoV 2 | SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere | Cardiac Complication | SARS Pneumonia

United States
Rutgers, The State University of New Jersey
University Hospital - Newark, NJ

No longer available

Investigational COVID-19 Convalescent Plasma Infusion for Severely or Life-threateningly Ill COVID-19 Patients

COVID-19 | SARS-CoV 2 | SARS-CoV Infection

United States
Royal Centre for Defence Medicine
Liverpool John Moores University; Leeds Beckett University

Unknown

Influence of Military Preventive Policy for reCruit Training on COVID-19 Seroconversion (IMPACTCOVID)

Covid19 | Vitamin D Deficiency | SARS-CoV Infection | Acute Respiratory Tract Infection

United Kingdom
National Institute of Allergy and Infectious Diseases...

Completed

Investigating Severe Acute Respiratory Syndrome (SARS)

SARS Virus

United States
Johns Hopkins University
Rush University Medical Center; University of California, San Francisco; amfAR...

Completed

COVID-19 Recovery Study: Symptoms and Biomarkers of Long COVID-19 in People Living With and Without HIV

HIV | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2)

United States
National Jewish Health

Recruiting

COVID-19 Vaccine Response in Chronic Respiratory Conditions

SARS-CoV Infection

United States
University Hospitals Cleveland Medical Center
Northwestern University

Withdrawn

Tele-health Enabled Clinical Trial for COVID-19

SARS-CoV Infection

United States
Royal Free Hospital NHS Foundation Trust
Roche Diagnostics

Completed

SARS-CoV-2 (COVID-19) Antibody PrevalencE in an Adult London HIV Cohort (SCAPE-HIV)

Covid19 | SARS-CoV Infection | HIV-1-infection

United Kingdom
Pfizer

Withdrawn

A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19 (EPIC-HOS)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Coronavirus Disease 2019 (COVID-19) | Immunocompromised | Hospitalization | Child, Hospitalized

United States, Bulgaria
UnitedHealth Group
Mayo Clinic; Bill and Melinda Gates Foundation; PATH

Completed

A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research

SARS-CoV Infection

United States
Chimerix

Terminated

Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Acute Lung Injury | Coronavirus Disease 2019 (COVID-19)

United States
Oneness Biotech Co., Ltd.

Completed

A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled MBS-COV (SNS812) in Healthy Participants

Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (Disorder)

United States
University of California, San Francisco
Rowpar Pharmaceuticals, Inc.

Terminated

Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19) (AMPoL)

Coronavirus Infections | COVID-19 | SARS-CoV 2 | Pharyngeal Diseases | Severe Acute Respiratory Syndrome Coronavirus 2 | Virus Disease

United States
National Institute of Allergy and Infectious Diseases...
Autoimmunity Centers of Excellence; Clinical Trials in Organ Transplantation...

Completed

COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C (PRISM)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Coronavirus Disease 2019 (COVID-19) | Multisystem Inflammatory Syndrome in Children (MIS-C)

United States
William Beaumont Hospitals

Terminated

Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2

Severe Acute Respiratory Syndrome | COVID-19 | SARS-COV2

United States
Cambridge Health Alliance

Completed

Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease

COVID | Oxidative Stress | Sars-CoV2 | SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere

United States
Apellis Pharmaceuticals, Inc.

Completed

A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19

Severe Acute Respiratory Syndrome | Coronavirus Infection | Covid-19 | COVID | Acute Respiratory Distress Syndrome | Coronavirus | Ards | Severe Acute Respiratory Syndrome Coronavirus 2 | Sars-CoV2

United States, Brazil
Cambridge Health Alliance
The Thoracic Foundation; Alturix

Not yet recruiting

NAC for Attenuation of COVID-19 Symptomatology (NACinCOVID2)

Covid19 | Oxidative Stress | SARS-CoV2 Infection | COVID-19 Pneumonia | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Respiratory Infection | SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere | COVID-19 Lower Respiratory Infection

United States
Allegheny Singer Research Institute (also known...
ElectroCore INC

Active, not recruiting

Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms (SAVIORII)

Respiratory Failure | COVID | Corona Virus Infection | Respiratory Distress Syndrome, Adult | SARS (Severe Acute Respiratory Syndrome) | ARDS, Human

United States
University of Chicago

Completed

Studies to Determine Whether Oxygen Sensing is Impaired in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Patients

Hypoxia | SARS-CoV-2 Acute Respiratory Disease | Carotid Bodies

United States
The Royal Wolverhampton Hospitals NHS Trust
University of Wolverhampton

Active, not recruiting

COVID-19 Health Professional Impact Study (CHIP)

Severe Acute Respiratory Syndrome | Coronavirus Infection

United Kingdom
ProgenaBiome
Rinati Skin, LLC

Withdrawn

A Study of ResCure™ to Treat COVID-19 Infection

Covid-19 | COVID | Corona Virus Infection | Sars-CoV2 | SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere | SARS Pneumonia | Coronavirus-19

United States

Clinical Trials on SARS (Severe Acute Respiratory Syndrome) in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations